MedPath

Ottawa Hospital Research Institute

Ottawa Hospital Research Institute logo
🇨🇦Canada
Ownership
Private
Established
2001-01-01
Employees
5K
Market Cap
-
Website
http://www.ohri.ca

Clinical Trials

532

Active:26
Completed:277

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:23
Phase 2:55
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (405 trials with phase data)• Click on a phase to view related trials

Not Applicable
228 (56.3%)
Phase 4
60 (14.8%)
Phase 2
55 (13.6%)
Phase 3
38 (9.4%)
Phase 1
23 (5.7%)
Early Phase 1
1 (0.2%)

Vacuum Therapy for the Treatment of Penile Numbness/Sensory Changes

Not Applicable
Recruiting
Conditions
Penile Numbness
First Posted Date
2025-09-12
Last Posted Date
2025-09-12
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
8
Registration Number
NCT07171567
Locations
🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

Microneedle Treatment of Chronic Phase Peyronie's Disease: A Pilot Clinical Trial

Not Applicable
Conditions
Peyronie's Disease
First Posted Date
2025-08-19
Last Posted Date
2025-08-19
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
10
Registration Number
NCT07128420
Locations
🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study

Not Applicable
Recruiting
Conditions
Type 2 Diabetes (T2DM)
Hypoglycemia (Diabetic)
First Posted Date
2025-07-30
Last Posted Date
2025-07-30
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
120
Registration Number
NCT07094529
Locations
🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants

Not Applicable
Not yet recruiting
Conditions
Bronchopulmonary Dysplasia (BPD)
ELGAN (22-28SA)
Interventions
Biological: Human Allogenic Umbilical Cord Mesenchymal Stromal Cells
Other: Sham procedure control
First Posted Date
2025-07-10
Last Posted Date
2025-07-10
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
168
Registration Number
NCT07058025
Locations
🇨🇦

Royal Alexandra Hospital/Stollery Children's Hospital, Edmonton, Alberta, Canada

🇨🇦

McMaster Children's Hospital, Hamilton, Ontario, Canada

🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

and more 5 locations

Lower Trapezius Tendon Transfer vs Partial Cuff Repair in Massive Rotator Cuff Tears

Not Applicable
Not yet recruiting
Conditions
Massive Rotator Cuff Tear
First Posted Date
2025-07-04
Last Posted Date
2025-07-04
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
60
Registration Number
NCT07051889
Locations
🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 106
  • Next

News

Tranexamic Acid Fails to Reduce Transfusions in Radical Cystectomy: TACT Trial

• A randomized, double-blind, placebo-controlled trial (TACT) assessed tranexamic acid (TXA) in patients undergoing radical cystectomy for bladder cancer. • The study found that TXA did not significantly reduce the need for red blood cell transfusions within 30 days post-surgery compared to placebo. • Secondary outcomes, including blood loss and thromboembolic events, also showed no significant differences between the TXA and placebo groups. • The findings suggest that routine use of TXA during open radical cystectomy for bladder cancer is not recommended.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.